| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Wyeth Farma S.A.. Autovia del Norte Испания |
506.4 |
101.28 |
607.68 |
4% |
10 |
516.4 |
103.28 |
619.68 |
16% |
25 |
541.4 |
108.28 |
649.68 |
Промяна на обстоятелства НСР-17756/17.01.2019 |
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г.; НСР-18103/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Wyeth Farma S.A.. Autovia del Norte Испания |
508.5 |
101.7 |
610.2 |
4% |
10 |
518.5 |
103.7 |
622.2 |
16% |
25 |
543.5 |
108.7 |
652.2 |
Промяна на обстоятелства НСР-17756/17.01.2019 |
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. |
17.12.2016 |
02.02.2019 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
508.5 |
101.7 |
610.2 |
4% |
10 |
518.5 |
103.7 |
622.2 |
16% |
25 |
543.5 |
108.7 |
652.2 |
|
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
508.5 |
101.7 |
610.2 |
4% |
10 |
518.5 |
103.7 |
622.2 |
16% |
25 |
543.5 |
108.7 |
652.2 |
|
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
520.11 |
104.02 |
624.13 |
4% |
10 |
530.11 |
106.02 |
636.13 |
16% |
25 |
555.11 |
111.02 |
666.13 |
|
НСР-7012/25.08.2015 |
10.09.2015 |
10.09.2015 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
520.11 |
104.02 |
624.13 |
4% |
10 |
530.11 |
106.02 |
636.13 |
16% |
25 |
555.11 |
111.02 |
666.13 |
|
НСР-7012/25.08.2015 |
10.09.2015 |
10.09.2015 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
EU/1/99/103/006 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A, Испания |
520.11 |
104.02 |
624.13 |
4% |
10 |
530.11 |
106.02 |
636.13 |
16% |
25 |
555.11 |
111.02 |
666.13 |
|
НСР-5767/09.03.2015 |
23.03.2015 |
23.03.2015 |
Неактивен |
3640 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
553.64 |
110.73 |
664.37 |
4% |
10 |
563.64 |
112.73 |
676.37 |
16% |
25 |
588.64 |
117.73 |
706.37 |
корекц. с Протокол 106/27.02.2015 |
НСР-2501/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/001-004 |
ReFacto AF, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
1107.23 |
221.45 |
1328.68 |
4% |
10 |
1117.23 |
223.45 |
1340.68 |
16% |
25 |
1142.23 |
228.45 |
1370.68 |
цената се заличава КЦРР-2536/14.03.2013 |
КЦРР-2039/21.01.2013 |
06.03.2013 |
06.03.2013 |
Заличен |
1648 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/001-004 |
ReFacto AF, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
280.09 |
56.02 |
336.11 |
4% |
10 |
290.09 |
58.02 |
348.11 |
16% |
25 |
315.09 |
63.02 |
378.11 |
КЦPP-1462/02.10.2012 промяна на обстоятелства; Цената е вписана в регистъра на пределните цени с решение НСР-3155/26.03.2014 |
КЦ-1970/26.01.2011 |
09.02.2011 |
09.02.2011 |
Заличен |
1013 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/001-004 |
ReFacto AF, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
1120.4 |
224.08 |
1344.48 |
4% |
10 |
1130.4 |
226.08 |
1356.48 |
16% |
25 |
1155.4 |
231.08 |
1386.48 |
|
КЦ-1894/02.11.2010 |
16.11.2010 |
16.11.2010 |
Неактивен |
1648 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/001-004 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
560.21 |
112.04 |
672.25 |
4% |
10 |
570.21 |
114.04 |
684.25 |
16% |
25 |
595.21 |
119.04 |
714.25 |
КЦPP-1462/02.10.2012 промяна на обстоятелства |
КЦ-1894/02.11.2010 |
16.11.2010 |
16.11.2010 |
Неактивен |
2453 |
| Metoclopramide |
20050444 |
Reglan, Tablet, 10, mg, Pack: 40 |
Алкалоид ЕООД, България |
Alkaloid-INT d.o.o. Slovenia |
1.73 |
0.35 |
2.08 |
7% |
0.12 |
1.85 |
0.37 |
2.22 |
20% |
0.35 |
2.2 |
0.44 |
2.64 |
промяна на обстоятелства решение КЦPP-2325/20.02.2013 |
КЦ-221/19.09.2008; НСР-9684/30.06.2016 |
21.10.2008 |
02.08.2016 |
Заличен |
98 |
| Metoclopramide |
15635/29.12.2006 г. |
Reglan, Tablet, 10, mg, Pack: 40 |
Алкалоид ЕООД, България |
Alkaloid-INT d.o.o. Slovenia |
1.73 |
0.35 |
2.08 |
7% |
0.12 |
1.85 |
0.37 |
2.22 |
20% |
0.35 |
2.2 |
0.44 |
2.64 |
промяна на обстоятелства решение КЦPP-2325/20.02.2013 |
КЦ-221/19.09.2008 |
21.10.2008 |
21.10.2008 |
Неактивен |
98 |
| Metoclopramide |
15634/29.12.2006 г. |
Reglan, Solution for injection, 10, mg, Pack: 30 |
Алкалоид ЕООД, България |
Алкалоид АД |
4.84 |
0.97 |
5.81 |
9% |
0.44 |
5.28 |
1.06 |
6.34 |
22% |
1.06 |
6.34 |
1.27 |
7.61 |
Цената е заличена с решение КЦРР-391/29.03.2012 |
КЦ-221/19.09.2008 |
21.10.2008 |
21.10.2008 |
Заличен |
99 |
| Zanamivir |
20010521 |
RELENZA, Inhalation powder, pre dispensed, 5 mg/dose x 4 doses x 5 rotadiskuses, -, Pack: 1 |
GlaxoSmithKline (Ireland) Limited, Ирландия |
Glaxo Wellcome Production, France |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Прот. № 220/20.04.2017 г.; Промяна на обстоятелства НСР-18247/22.03.2019 |
НСР-4817/13.10.2014 |
27.10.2014 |
02.05.2019 |
Активен |
3262 |
| Zanamivir |
20010521 |
RELENZA, Inhalation powder, pre dispensed, 5 mg/dose x 4 doses x 5 rotadiskuses, -, Pack: 1 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome Production, France |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Прот. № 220/20.04.2017 г. |
НСР-4817/13.10.2014 |
27.10.2014 |
02.05.2017 |
Неактивен |
3262 |
| Zanamivir |
20010521 |
RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome Production, France |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
|
НСР-4817/13.10.2014 |
27.10.2014 |
27.10.2014 |
Неактивен |
3262 |
| Zanamivir |
20010521 |
RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome Production, France |
24.19 |
4.84 |
29.03 |
6% |
1.45 |
25.64 |
5.13 |
30.77 |
18% |
4.35 |
29.99 |
6 |
35.99 |
|
НСР-2539/24.01.2014 |
20.02.2014 |
20.02.2014 |
Неактивен |
3262 |
| Zanamivir |
20010521 |
RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome Production, France |
24.25 |
4.85 |
29.1 |
6% |
1.46 |
25.71 |
5.14 |
30.85 |
18% |
4.37 |
30.08 |
6.02 |
36.1 |
|
КЦРР-2779/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
3262 |
| Zanamivir |
0805/10.10.2007 г. |
RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome Production, France |
24.43 |
4.89 |
29.32 |
6% |
1.47 |
25.9 |
5.18 |
31.08 |
18% |
4.4 |
30.3 |
6.06 |
36.36 |
|
КЦ-881/18.05.2009 |
01.06.2009 |
01.06.2009 |
Неактивен |
3262 |
| Fluticasone furoate, Vilanterol |
EU/1/13/886/002 |
Relvar Ellipta, Inhalation powder, pre dispensed, 92 mcg/22 mcg, UD, Pack: 30 doses |
GlaxoSmithKline (Ireland) Limited, Ирландия |
Glaxo Operations UK Ltd. (trading as Glaxo Wellcome Operations), UK |
49.17 |
9.83 |
59 |
4% |
1.97 |
51.14 |
10.23 |
61.37 |
16% |
7.87 |
59.01 |
11.8 |
70.81 |
Отхвърлена жалба от Комисия по прозрачност КП-360/26.08.2015; Промяна на обстоятелства НСР-18154/07.03.2019 |
НСР-6382/03.06.2015.; НСР-9363/19.05.2016; НСР-13589/25.08.2017; НСР-15732/25.05.2018; НСР-19271/18.07.2019 |
02.08.2019 |
02.09.2019 |
Активен |
3177 |
| Fluticasone furoate, Vilanterol |
EU/1/13/886/002 |
Relvar Ellipta, Inhalation powder, pre dispensed, 92 mcg/22 mcg, UD, Pack: 30 doses |
GlaxoSmithKline (Ireland) Limited, Ирландия |
Glaxo Operations UK Ltd. (trading as Glaxo Wellcome Operations), UK |
49.72 |
9.94 |
59.66 |
4% |
1.99 |
51.71 |
10.34 |
62.05 |
16% |
7.96 |
59.67 |
11.93 |
71.6 |
Отхвърлена жалба от Комисия по прозрачност КП-360/26.08.2015; Промяна на обстоятелства НСР-18154/07.03.2019 |
НСР-6382/03.06.2015.; НСР-9363/19.05.2016; НСР-13589/25.08.2017; НСР-15732/25.05.2018 |
09.06.2018 |
02.04.2019 |
Неактивен |
3177 |
| Fluticasone furoate, Vilanterol |
EU/1/13/ 886/005 |
Relvar Ellipta, Inhalation powder, pre dispensed, 184 mcg/22 mcg, UD, Pack: 30 doses |
GlaxoSmithKline (Ireland) Limited, Ирландия |
Glaxo Operations UK Ltd. (trading as Glaxo Wellcome Operations), UK |
57.5 |
11.5 |
69 |
4% |
2.3 |
59.8 |
11.96 |
71.76 |
16% |
9.2 |
69 |
13.8 |
82.8 |
Промяна на обстоятелства НСР-18241/22.03.2019 |
НСР-6381/03.06.2015.; НСР-19272/18.07.2019 |
02.08.2019 |
02.09.2019 |
Активен |
3176 |
| Fluticasone furoate, Vilanterol |
EU/1/13/ 886/005 |
Relvar Ellipta, Inhalation powder, pre dispensed, 184 mcg/22 mcg, UD, Pack: 30 doses |
GlaxoSmithKline (Ireland) Limited, Ирландия |
Glaxo Operations UK Ltd. (trading as Glaxo Wellcome Operations), UK |
58.67 |
11.73 |
70.4 |
4% |
2.35 |
61.02 |
12.2 |
73.22 |
16% |
9.39 |
70.41 |
14.08 |
84.49 |
Промяна на обстоятелства НСР-18241/22.03.2019 |
НСР-6381/03.06.2015. |
18.06.2015 |
02.05.2019 |
Неактивен |
3176 |